EPCAM and neoplasm: Both UBS54 and Y6V-iIL-12 CAR-T cells suppressed the progression of SRCC24 tumors which expressed strong EpCAM, in comparison with insignificant tumor killing by NT, Y6V, and iIL-12 T cells.